InsideTrading SEC Form 4 insider trades

Stocks

LYEL Lyell Immunopharma, Inc.

Healthcare · Pharmaceutical Preparations · Market cap: $351.6M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $0 2022-Q2: bought $0, sold $0 2022-Q3: bought $0, sold $71.0K 2022-Q4: bought $0, sold $0 2023-Q1: bought $0, sold $0 2023-Q2: bought $0, sold $0 2023-Q3: bought $0, sold $132.3K 2023-Q4: bought $0, sold $0 2024-Q1: bought $0, sold $0 2024-Q2: bought $0, sold $0 2024-Q3: bought $0, sold $0 2024-Q4: bought $0, sold $0 2025-Q1: bought $449.5K, sold $0 2025-Q2: bought $0, sold $0 2025-Q3: bought $0, sold $133.5K 2025-Q4: bought $0, sold $88.4K 2026-Q1: bought $25.0M, sold $264.3K 2026-Q2: bought $0, sold $40.6K 2026-Q3: bought $0, sold $211.3K 2026-Q4: bought $50.0M, sold $22.4K
Bought, above the line (largest quarter $50.0M) Sold, below the line (largest quarter $264.3K)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$0
2022-Q2$0$0
2022-Q3$0$71.0K
2022-Q4$0$0
2023-Q1$0$0
2023-Q2$0$0
2023-Q3$0$132.3K
2023-Q4$0$0
2024-Q1$0$0
2024-Q2$0$0
2024-Q3$0$0
2024-Q4$0$0
2025-Q1$449.5K$0
2025-Q2$0$0
2025-Q3$0$133.5K
2025-Q4$0$88.4K
2026-Q1$25.0M$264.3K
2026-Q2$0$40.6K
2026-Q3$0$211.3K
2026-Q4$50.0M$22.4K

Insider activity

Download CSV Up to 5,000 rows
Bought$75.4M9 buy days
Sold$963.8K47 sell days
Net insider flow+$74.5Mnet buying · 5 years
Latest trade2026-11-10Seely Lynn
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-11-10 Sell Seely Lynn CEO 545 $15.93 $8.7K 1
2026-11-10 Sell Bulis Veronica Sanchez VP 416 $15.93 $6.6K 1
2026-11-10 Sell Lee Gary K. Other C-suite 129 $15.93 $2.1K 1
2026-11-10 Sell Hill Stephen J. COO 88 $15.93 $1.4K 1
2026-11-04 Buy ARCH Venture Fund IX, L.P. 10% owner 2,321,262 $10.77 $25.0M 1
2026-11-04 Buy BERNS PAUL L 10% owner 2,321,262 $10.77 $25.0M 1
2026-10-12 Sell Aguirre Jarrad Mattieu Other C-suite 422 $8.63 $3.6K 1
2026-09-10 Sell Shook David Other C-suite 500 $12.70 $6.4K 1
2026-08-21 Sell Seely Lynn CEO 9,589 $15.54 $149.0K 1
2026-08-21 Sell Lee Gary K. Other C-suite 1,457 $15.54 $22.6K 1
2026-08-21 Sell Hill Stephen J. COO 989 $15.54 $15.4K 1
2026-08-10 Sell Bulis Veronica Sanchez VP 621 $14.34 $8.9K 1
2026-08-10 Sell Seely Lynn CEO 390 $14.34 $5.6K 1
2026-08-10 Sell Lee Gary K. Other C-suite 131 $14.34 $1.9K 1
2026-08-10 Sell Hill Stephen J. COO 89 $14.34 $1.3K 1
2026-07-17 Sell Innovative Cellular Therapeutics Holdings Ltd 10% owner 10 $13.70 $137 1
2026-07-16 Sell Innovative Cellular Therapeutics Holdings Ltd 10% owner 10 $13.73 $137 1
2026-06-10 Sell Shook David Other C-suite 1,977 $12.64 $25.0K 1
2026-05-11 Sell Seely Lynn CEO 388 $18.91 $7.3K 1
2026-05-11 Sell Bulis Veronica Sanchez VP 217 $18.91 $4.1K 1
2026-05-11 Sell Lee Gary K. Other C-suite 130 $18.92 $2.5K 1
2026-05-11 Sell Hill Stephen J. COO 89 $18.92 $1.7K 1
2026-03-06 Buy ARCH Venture Fund IX, L.P. 10% owner 488,090 $25.61 $12.5M 1
2026-03-06 Buy BERNS PAUL L 10% owner 488,090 $25.61 $12.5M 1
2026-02-11 Sell Seely Lynn CEO 7,455 $23.39 $174.4K 1
2026-02-11 Sell Lee Gary K. Other C-suite 1,671 $23.39 $39.1K 1
2026-02-11 Sell Hill Stephen J. COO 1,236 $23.39 $28.9K 1
2026-02-10 Sell Seely Lynn CEO 438 $23.12 $10.1K 1
2026-02-10 Sell Bulis Veronica Sanchez VP 254 $23.12 $5.9K 1
2026-02-10 Sell Lee Gary K. Other C-suite 147 $23.12 $3.4K 1
2026-02-10 Sell Hill Stephen J. COO 109 $23.12 $2.5K 1
2025-12-30 Sell Bulis Veronica Sanchez VP 936 $32.32 $30.3K 1
2025-12-24 Sell Bulis Veronica Sanchez VP 1,136 $38.67 $43.9K 1
2025-11-10 Sell Seely Lynn CEO 412 $16.11 $6.6K 1
2025-11-10 Sell Bulis Veronica Sanchez VP 239 $16.10 $3.8K 1
2025-11-10 Sell Lee Gary K. Other C-suite 138 $16.16 $2.2K 1
2025-11-10 Sell Hill Stephen J. COO 95 $16.12 $1.5K 1
2025-08-21 Sell Seely Lynn CEO 7,257 $10.54 $76.5K 1
2025-08-21 Sell Lee Gary K. Other C-suite 1,453 $10.54 $15.3K 1
2025-08-21 Sell Newton Charles W. CFO 1,453 $10.54 $15.3K 1
2025-08-21 Sell Hill Stephen J. COO 1,004 $10.54 $10.6K 1
2025-08-12 Sell Seely Lynn CEO 406 $10.34 $4.2K 1
2025-08-12 Sell Lee Gary K. Other C-suite 136 $10.34 $1.4K 1
2025-08-12 Sell Newton Charles W. CFO 136 $10.34 $1.4K 1
2025-08-12 Sell Hill Stephen J. COO 94 $10.34 $972 1
2025-08-11 Sell Seely Lynn CEO 391 $10.53 $4.1K 1
2025-08-11 Sell Newton Charles W. CFO 131 $10.53 $1.4K 1
2025-08-11 Sell Lee Gary K. Other C-suite 131 $10.53 $1.4K 1
2025-08-11 Sell Hill Stephen J. COO 91 $10.53 $958 1
2025-03-31 Buy BRAWLEY OTIS W Director 35,640 $0.56 $20.0K 1
2025-03-21 Buy Ramachandra Sumant Director 200,000 $0.58 $116.0K 1
2025-03-17 Buy Newton Charles W. CFO 200,000 $0.56 $112.0K 1
2025-03-14 Buy Seely Lynn CEO 175,000 $0.61 $106.8K 1
2025-03-14 Buy Klausner Richard Director 158,000 $0.60 $94.8K 1
2023-08-15 Sell Klausner Richard Director 58,020 $2.28 $132.3K 1
2022-09-23 Sell Klausner Richard Director 11,100 $6.40 $71.0K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
ARCH Venture Fund IX, L.P. 10% owner $37.5M $0 2026-11-04
BERNS PAUL L 10% owner $37.5M $0 2026-11-04
Seely Lynn CEO $106.8K $446.6K 2026-11-10
Klausner Richard Director $94.8K $203.3K 2025-03-14
Newton Charles W. CFO $112.0K $18.1K 2025-08-21
Ramachandra Sumant Director $116.0K $0 2025-03-21
Bulis Veronica Sanchez VP $0 $103.5K 2026-11-10
Lee Gary K. Other C-suite $0 $91.8K 2026-11-10
Hill Stephen J. COO $0 $65.2K 2026-11-10
Shook David Other C-suite $0 $31.3K 2026-09-10
BRAWLEY OTIS W Director $20.0K $0 2025-03-31
Aguirre Jarrad Mattieu Other C-suite $0 $3.6K 2026-10-12
Innovative Cellular Therapeutics Holdings Ltd 10% owner $0 $274 2026-07-17

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2025-03-14 → 2025-03-31 5 $449.5K 65 -11.4% (-19.7% raw)-14.7% (-11.3% raw)-4.0% (+17.0% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.